SMTL ID : 2zm3.5 (4 other biounits)

Complex Structure of Insulin-like Growth Factor Receptor and Isoquinolinedione Inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

homo-octamer

Ligands

8 x 575: (4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione(Non-covalent)

575.1: 14 residues within 4Å: Chain A: L.27, Q.29, G.30, V.35, A.53, V.85, M.101, E.102, L.103, M.104, T.105, R.106, G.107, M.164 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.27, A:L.27, A:V.35 Hydrogen bonds: A:E.102, A:M.104, A:M.104 Water bridges: A:R.25 Halogen bonds: A:Q.29 575.2: 14 residues within 4Å: Chain B: L.27, Q.29, G.30, V.35, A.53, V.85, M.101, E.102, L.103, M.104, T.105, R.106, G.107, M.164 8 PLIP interactions: 8 interactions with chain B Hydrophobic interactions: B:L.27, B:L.27, B:V.35 Hydrogen bonds: B:E.102, B:M.104, B:M.104 Water bridges: B:R.25 Halogen bonds: B:Q.29 575.3: 15 residues within 4Å: Chain C: R.25, L.27, Q.29, G.30, V.35, A.53, V.85, M.101, E.102, L.103, M.104, T.105, R.106, G.107, M.164 8 PLIP interactions: 8 interactions with chain C Hydrophobic interactions: C:L.27, C:L.27, C:V.35 Hydrogen bonds: C:E.102, C:M.104, C:M.104 Water bridges: C:R.25 Halogen bonds: C:Q.29 575.4: 15 residues within 4Å: Chain D: R.25, L.27, Q.29, G.30, V.35, A.53, V.85, M.101, E.102, L.103, M.104, T.105, R.106, G.107, M.164 8 PLIP interactions: 8 interactions with chain D Hydrophobic interactions: D:L.27, D:L.27, D:V.35 Hydrogen bonds: D:E.102, D:M.104, D:M.104 Water bridges: D:R.25 Halogen bonds: D:Q.29 575.5: 14 residues within 4Å: Chain E: L.27, Q.29, V.35, A.53, K.55, V.85, M.101, E.102, L.103, M.104, T.105, R.106, G.107, M.164 7 PLIP interactions: 7 interactions with chain E Hydrophobic interactions: E:L.27, E:L.27, E:A.53 Hydrogen bonds: E:E.102, E:M.104, E:M.104 Halogen bonds: E:Q.29 575.6: 14 residues within 4Å: Chain F: L.27, Q.29, G.30, V.35, A.53, V.85, M.101, E.102, L.103, M.104, T.105, R.106, G.107, M.164 7 PLIP interactions: 7 interactions with chain F Hydrophobic interactions: F:L.27, F:V.35, F:A.53 Hydrogen bonds: F:E.102, F:M.104, F:M.104 Halogen bonds: F:Q.29 575.7: 14 residues within 4Å: Chain G: L.27, Q.29, V.35, A.53, K.55, V.85, M.101, E.102, L.103, M.104, T.105, R.106, G.107, M.164 7 PLIP interactions: 7 interactions with chain G Hydrophobic interactions: G:L.27, G:L.27, G:A.53 Hydrogen bonds: G:E.102, G:M.104, G:M.104 Halogen bonds: G:Q.29 575.8: 14 residues within 4Å: Chain H: L.27, Q.29, G.30, V.35, A.53, V.85, M.101, E.102, L.103, M.104, T.105, R.106, G.107, M.164 7 PLIP interactions: 7 interactions with chain H Hydrophobic interactions: H:L.27, H:V.35, H:A.53 Hydrogen bonds: H:E.102, H:M.104, H:M.104 Halogen bonds: H:Q.29

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Mayer, S.C. et al., Lead identification to generate isoquinolinedione inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment. Bioorg.Med.Chem.Lett. (2008)

Release Date

2008-06-10

Peptides

Insulin-like growth factor 1 receptor: ABCDEFGH

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

C
D

D
D

E
B

F
C

G
B

H
C

Insulin-like growth factor 1 receptor

Related Entries With Identical Sequence